$0.53
7.00% day before yesterday
Nasdaq, Sep 06, 10:12 pm CET
ISIN
US09609G1004
Symbol
BLUE
Sector
Industry

bluebird bio, Inc. Target price 2024 - Analyst rating & recommendation

bluebird bio, Inc. Classifications & Recommendation:

Buy
30%
Hold
60%
Sell
10%

bluebird bio, Inc. Price Target

Target Price $3.14
Price $0.53
Potential
Number of Estimates 7
7 Analysts have issued a price target bluebird bio, Inc. 2025 . The average bluebird bio, Inc. target price is $3.14. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 10 analysts: 3 Analysts recommend bluebird bio, Inc. to buy, 6 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the bluebird bio, Inc. stock has an average upside potential 2025 of . Most analysts recommend the bluebird bio, Inc. stock at Hold.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Million $ 29.50 100.52
719.44% 240.76%

10 Analysts have issued a sales forecast bluebird bio, Inc. 2024 . The average bluebird bio, Inc. sales estimate is

$101m
Unlock
. This is
362.60% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$168m 670.82%
Unlock
, the lowest is
$64.0m 194.52%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $29.5m 719.44%
2024
$101m 240.76%
Unlock
2025
$254m 152.70%
Unlock
2026
$343m 34.96%
Unlock
2027
$248m 27.66%
Unlock
2028
$325m 31.05%
Unlock

5 Analysts have issued an bluebird bio, Inc. EBITDA forecast 2024. The average bluebird bio, Inc. EBITDA estimate is

$-269m
Unlock
. This is
17.63% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-190m 41.90%
Unlock
, the lowest is
$-325m 0.52%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025
$-188m 30.15%
Unlock
2026
$-83.0m 55.86%
Unlock

EBITDA Margin

2025
-73.99% 72.36%
Unlock
2026
-24.20% 67.29%
Unlock

11 bluebird bio, Inc. Analysts have issued a net profit forecast 2024. The average bluebird bio, Inc. net profit estimate is

$-166m
Unlock
. This is
110.01% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-112m 41.89%
Unlock
, the lowest is
$-245m 209.46%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025
$-92.5m 44.40%
Unlock
2026
$-58.2m 37.12%
Unlock

Net Margin

2025
-36.40% 78.00%
Unlock
2026
-16.96% 53.41%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
P/E negative
EV/Sales 2.21

11 Analysts have issued a bluebird bio, Inc. forecast for earnings per share. The average bluebird bio, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$-1.55
Unlock
. This is
109.46% lower
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$-1.05 41.89%
Unlock
, the lowest is
$-2.29 209.46%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025
$-0.86 44.52%
Unlock
2026
$-0.54 37.21%
Unlock

P/E ratio

Current -0.71 2.74%
2024
-0.34 52.11%
Unlock
2025
-0.61 79.41%
Unlock
2026
-0.97 59.02%
Unlock

Based on analysts' sales estimates for 2024, the bluebird bio, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 10.24 79.81%
2024
2.21 78.39%
Unlock
2025
0.88 60.43%
Unlock
2026
0.65 25.91%
Unlock
2027
0.90 38.25%
Unlock
2028
0.68 23.70%
Unlock

P/S ratio

Current 4.69 89.42%
2024
1.01 78.38%
Unlock
2025
0.40 60.43%
Unlock
2026
0.30 25.89%
Unlock
2027
0.41 38.20%
Unlock
2028
0.31 23.67%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today